VIP and PACAP inhibit IL-12 production in LPS-stimulated macrophages. Subsequent effect on IFNγ synthesis by T cells
- 3 May 1999
- journal article
- Published by Elsevier BV in Journal of Neuroimmunology
- Vol. 96 (2), 167-181
- https://doi.org/10.1016/s0165-5728(99)00023-5
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-JunPublished by Elsevier BV ,1998
- Proinflammatory and Immunoregulatory Functions of Interleukin-12International Reviews of Immunology, 1998
- Functional characterization and mRNA expression of pituitary adenylate cyclase activating polypeptide (PACAP) type I receptors in rat peritoneal macrophagesBiochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1997
- The C-terminus ends of secretin and VIP interact with the N-terminal domains of their receptorsPeptides, 1996
- Immunosuppressive retroviral peptides: cAMP and cytokine patternsImmunology Today, 1995
- Interleukin‐12 is required for interferon‐γ production and lethality in lipopolysaccharide‐induced shock in miceEuropean Journal of Immunology, 1995
- Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complexJournal of Neuroimmunology, 1994
- Interleukin‐10 controls interferon‐γ and tumor necrosis factor production during experimental endotoxemiaEuropean Journal of Immunology, 1994
- Development of T H 1 CD4 + T Cells Through IL-12 Produced by Listeria -Induced MacrophagesScience, 1993
- Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells.The Journal of Experimental Medicine, 1992